Sequencing and Combo Therapy

Learning Objectives:

Discuss whether there is a right or wrong approach to medication sequencing in IBD
Review the role of advanced combination therapy in 2026
Highlight what is coming that may change your approach to sequencing and combination treatment beyond 2026

Speaker:

Dr. Christopher Ma, MD, MPH, FRCPC

IBD Unit, Division of Gastroenterology & Hepatology, University of Calgary

Chris Ma is a gastroenterologist at the University of Calgary. His clinical interest is primarily in the management of complex inflammatory bowel disease, and his research focuses on the design and execution of clinical trials in IBD.

Back to Main Website Close X